Serum GDF-15 levels are significantly increased in CAD patients compared to healthy controls, with a positive correlation shown between GDF-15 and Gensini scores, which suggests that GDF-15 is useful not only in discriminating patients with CAD but also in identifying patients with more severe CAD [20]. The gene discussed is GDF15; the disease is coronary artery disorder.